Sort
4,870 grants matching “glp 1”
Identification of diagnostic and dosage markers from sulfur mustard exposure
$446,677Susan Esther Boggs · Lovelace Biomedical & Environmental Research Institute · U54 · FY2007 · NS
Animal models to assess efficacy of countermeasures for SM-induced toxicity
$446,639Janet M. Benson · Lovelace Biomedical & Environmental Research Institute · U54 · FY2010 · NS
University of Maryland, Baltimore Biomarker Reference Laboratory
$446,149Sanford A Stass · University Of Maryland Baltimore · U24 · FY2019 · CA
Mechanisms underlying GLP-1 receptor mediated relief of Parkinsonâs disease symptoms
$445,500Daniel S McGehee · University Of Chicago · R21 · FY2019 · NS
Drug Development of GLP-1 receptor agonists
$444,457Josephine M Egan · National Institute On Aging · Z01 · FY2008 · AG
The role of GLP-1 and CCK in the pancreatic islet to promote beta-cell survival
$444,245Dawn B Davis · University Of Wisconsin-Madison · R01 · FY2019 · DK
Bioabsorbable Magnesium (Mg) Implants for Craniomaxillofacial Surgical Systems
$444,138Stephen Lebeau · Nanomag, Llc · R44 · FY2019 · DE
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
$444,056Matthias G. Von Herrath · La Jolla Institute For Immunology · U01 · FY2009 · DK
"Subunit Vaccines for Brucella Pathogens"
$444,037David W Pascual · University Of Florida · R01 · FY2013 · AI
Renal dopamine-1 receptor defect in hypertension
$442,951Pedro A. Jose · George Washington University · R01 · FY2017 · DK
Harnessing the biology of glycosphingolipid trafficking for biologic drug delivery
$442,500Wayne Lencer · Boston Children'S Hospital · R01 · FY2017 · DK
Harnessing the biology of glycosphingolipid trafficking for biologic drug delivery
$442,500Wayne Lencer · Boston Children'S Hospital · R01 · FY2018 · DK
Harnessing the biology of glycosphingolipid trafficking for biologic drug delivery
$442,500Wayne Lencer · Boston Children'S Hospital · R01 · FY2019 · DK
Harnessing the biology of glycosphingolipid trafficking for biologic drug delivery
$442,500Wayne Lencer · Boston Children'S Hospital · R01 · FY2016 · DK
Paracrine regulation of islet cell function by primary cilia
$442,310Jing Wang Hughes · Washington University · R01 · FY2025 · DK
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master
$442,262Lichun Lu · Mayo Clinic Rochester · R01 · FY2016 · AR
Cellular and Synaptic Hypothalamic Reorganization After Exercise Training
$442,034Kevin W Williams · Ut Southwestern Medical Center · P01 · FY2021 · DK
Novel metabolic actions of GIP
$441,836Jonathan E Campbell · Duke University · R01 · FY2023 · DK
Development of a first-in-class nonmuscle myosin II inhibitor to prevent substance use disorder relapse
$440,888Erica J Young · Myosin Therapeutics Inc. · R44 · FY2023 · DA
CENTRAL GLP-1 SYSTEMS IN COUNTER REGULATORY RESPONSES
$440,582Beth Israel Deaconess Medical Center · R01 · FY2002 · DK
Electronic Bypass for Diabetes
$439,552Jiande Chen · Johns Hopkins University · R01 · FY2019 · DK
Development, Formulation and Inhalational Delivery of a New Peptide for ILD
$439,300Sreerama Shetty · University Of Texas Hlth Ctr At Tyler · R01 · FY2024 · HL
Core--Development and analysis of SOD/Catalase mimetics
$439,232Susan Doctrow · Medical College Of Wisconsin · U19 · FY2006 · AI
Biobehavioral Prediction of Illness Trajectory in Bulimic Syndromes
$438,963Pamela K. Keel · Florida State University · R01 · FY2017 · MH
Identification of diagnostic and dosage markers from sulfur mustard exposure
$438,878Susan Esther Boggs · Lovelace Biomedical & Environmental Research Institute · U54 · FY2010 · NS